Page 8 - Global Growth Pharmaceuticals & Biotech Stocks

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

UPDATED Mar 11, 2026

Discover Global Pharmaceuticals & Biotech Growth Stocks from around the world. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

3,015 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
IMCR	US$32.52	-3.6%	11.9%	US$1.7b	US$65.01	4.1	63.7%	n/a
PRAX	US$296.97	-4.4%	696.4%	US$8.3b	US$600.71	9.4	63.4%	n/a
INDP	US$1.76	-12.4%	-92.5%	US$4.2m	US$10.00	0.9	63.3%	n/a
INSM	US$139.40	-7.0%	88.3%	US$31.0b	US$212.53	49.5	63.3%	n/a
IDIA	CHF 3.89	6.3%	255.6%	CHF 978.4m	CHF 4.83	4.4	63.2%	n/a
A096530	₩22,350.00	-5.9%	-9.5%	₩1.0t	₩39,500.00	2.2	63.1%	3.6%
MSB	AU$2.14	-1.8%	2.9%	AU$2.8b	AU$3.90	30.2	62.7%	n/a
RYTM	US$90.02	-1.1%	75.4%	US$6.4b	US$140.20	32.4	62.7%	n/a
GERN	US$1.66	12.9%	-6.2%	US$1.0b	US$3.40	5.8	62.5%	n/a
MRKR	US$1.37	-4.9%	-2.1%	US$23.5m	US$7.87	4.9	62.4%	n/a
IMMU	SEK 4.10	-4.7%	-39.3%	SEK 251.5m	SEK 15.00	0.4	61.9%	n/a
BBIO	US$71.39	7.3%	119.1%	US$14.4b	US$99.96	27.6	61.8%	n/a
CANF	₪6.41	-56.7%	-88.8%	₪16.8m	n/a	9.6	61.7%	n/a
SVA	CA$0.17	3.0%	-2.9%	CA$56.3m	n/a	-3.7	61.5%	n/a
SMMT	US$16.08	7.6%	-16.2%	US$12.4b	US$31.42	18.9	61.5%	n/a
COGT	US$36.08	-2.5%	375.4%	US$5.9b	US$53.83	10.6	61.4%	n/a
ADCT	US$4.88	15.1%	163.8%	US$609.8m	US$8.00	7.6	61.3%	n/a
RLYB	US$9.98	-5.0%	89.3%	US$52.9m	n/a	78.3	61.2%	n/a
KPRX	US$2.17	6.4%	-33.4%	US$8.0m	US$12.00	0.4	61.1%	n/a
KURN	CHF 28.44	3.8%	43.9%	CHF 1.1b	CHF 34.65	10.8	60.9%	n/a
OMER	US$11.93	2.9%	48.9%	US$830.2m	US$38.00	-7.0	60.9%	n/a
CMPX	US$5.59	-1.8%	122.7%	US$1.0b	US$13.64	5.1	60.8%	n/a
NAMS	US$31.35	0.5%	34.2%	US$3.6b	US$48.33	160.2	60.8%	n/a
CDXS	US$1.27	17.6%	-54.0%	US$112.0m	US$6.58	2.2	60.8%	n/a

Page 8 of 126